The Committee will work with all stakeholders, state governments and vaccine manufacturers.
“The Committee of Experts on Vaccine Management under the chairmanship of Dr. V K Paul, NITI Aayog will meet on August 12 to discuss the logistical and moral facets of the acquisition and management of the COVID19 vaccine,” the ministry tweeted.
“The Committee will have interaction with all stakeholders, adding state governments and vaccine manufacturers,” he said in a tweet.
According to the Indian Medical Research Council (ICMR), 3 Indian COVID-19 vaccines are lately in clinical trial stages.
“Right now, we have 3 Indian vaccines that are in other stages of clinical trials. The two vaccines, the Bharat Biotech vaccine and the Zydus Cadila DNA vaccine, have completed Phase 1 and will begin Phase 2, while the third is the Oxford vaccine.” said ICMR chief scientist (professor) Balram Bhargava.
“The Oxford vaccine, manufactured through the Serum Institute of India (SII), was approved for Phase 2 and 3 clinical trials, which begin within a week at 17 sites,” he added.
The number of COVID-19s in India surpassed the mark of 22 lakh, adding 6,34,945 active cases, 15.35,744 cured/unloaded/migrated while the accumulated balance sheet reached 44386.
However, the Ministry of Health noted that the infection is now concentrated in 10 states that contribute to more than 80% of new cases.
Click here to read Mint ePaperLivemint.com is now on Telegram. Join the Livemint channel on your telegram and updated
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any of our emails, check your spam folder.